✦ LIBER ✦

Phase II Trial of Combination of Pegylated Liposomal Doxorubicin, Cisplatin, and Infusional 5-Fluorouracil (CCF) Plus Trastuzumab as Preoperative Treatment for Locally Advanced and Inflammatory Breast Cancer

✍ Scribed by Rosalba Torrisi; Anna Cardillo; Giuseppe Cancello; Silvia Dellapasqua; Alessandra Balduzzi; Raffaella Ghisini; Alberto Luini; Paolo Veronesi; Giuseppe Viale; Aron Goldhirsch; Marco Colleoni

Book ID: 115075892
Publisher: CIG Media Group, LP.
Year: 2010
Tongue: English
Weight: 746 KB
Volume: 10
Category: Article
ISSN: 1526-8209
DOI: 10.3816/cbc.2010.n.064

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I/II trial of non-pegylated lipo

A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancer

✍ D. Amadori; C. Milandri; G. Comella; S. Saracchini; S. Salvagni; C. Barone; R. B 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 226 KB

Non-pegylated liposomal doxorubicin comb

Non-pegylated liposomal doxorubicin combined with gemcitabine as first-line treatment for metastatic or locally advanced breast cancer. Final results of a phase I/II trial

✍ S. Del Barco; R. Colomer; L. Calvo; I. Tusquets; E. Adrover; P. Sánchez; J. Rifà 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 220 KB